Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
- PMID: 32697968
- PMCID: PMC7332439
- DOI: 10.1016/j.cell.2020.06.043
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
Abstract
A SARS-CoV-2 variant carrying the Spike protein amino acid change D614G has become the most prevalent form in the global pandemic. Dynamic tracking of variant frequencies revealed a recurrent pattern of G614 increase at multiple geographic levels: national, regional, and municipal. The shift occurred even in local epidemics where the original D614 form was well established prior to introduction of the G614 variant. The consistency of this pattern was highly statistically significant, suggesting that the G614 variant may have a fitness advantage. We found that the G614 variant grows to a higher titer as pseudotyped virions. In infected individuals, G614 is associated with lower RT-PCR cycle thresholds, suggestive of higher upper respiratory tract viral loads, but not with increased disease severity. These findings illuminate changes important for a mechanistic understanding of the virus and support continuing surveillance of Spike mutations to aid with development of immunological interventions.
Keywords: COVID-19; PCR cycle threshold; SARS-CoV-2; Spike; antibody; diversity; evolution; infectivity; neutralization; pseudovirus.
Published by Elsevier Inc.
Conflict of interest statement
Declaration of Interests The authors declare no competing interests.
Figures















Comment in
-
Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear.Cell. 2020 Aug 20;182(4):794-795. doi: 10.1016/j.cell.2020.06.040. Epub 2020 Jul 3. Cell. 2020. PMID: 32697970 Free PMC article.
-
Emergence of a new SARS-CoV-2 variant in the UK.J Infect. 2021 Apr;82(4):e27-e28. doi: 10.1016/j.jinf.2020.12.024. Epub 2020 Dec 28. J Infect. 2021. PMID: 33383088 Free PMC article. No abstract available.
Similar articles
-
D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage.mBio. 2021 Aug 31;12(4):e0058721. doi: 10.1128/mBio.00587-21. Epub 2021 Jul 27. mBio. 2021. PMID: 34311586 Free PMC article.
-
Stability of SARS-CoV-2 Spike G614 Variant Surpasses That of the D614 Variant after Cold Storage.mSphere. 2021 Mar 31;6(2):e00104-21. doi: 10.1128/mSphere.00104-21. mSphere. 2021. PMID: 33789940 Free PMC article.
-
Spike mutation D614G alters SARS-CoV-2 fitness.Nature. 2021 Apr;592(7852):116-121. doi: 10.1038/s41586-020-2895-3. Epub 2020 Oct 26. Nature. 2021. PMID: 33106671 Free PMC article.
-
[Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).].Vopr Virusol. 2020;65(2):62-70. doi: 10.36233/0507-4088-2020-65-2-62-70. Vopr Virusol. 2020. PMID: 32515561 Review. Russian.
-
Angiotensin-converting enzyme 2: The old door for new severe acute respiratory syndrome coronavirus 2 infection.Rev Med Virol. 2020 Sep;30(5):e2122. doi: 10.1002/rmv.2122. Epub 2020 Jun 30. Rev Med Virol. 2020. PMID: 32602627 Free PMC article. Review.
Cited by
-
Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants.J Ethnopharmacol. 2021 Jun 28;274:114016. doi: 10.1016/j.jep.2021.114016. Epub 2021 Mar 12. J Ethnopharmacol. 2021. PMID: 33716085 Free PMC article.
-
Tracking the onset date of the community spread of SARS-CoV-2 in western countries.Mem Inst Oswaldo Cruz. 2020;115:e200183. doi: 10.1590/0074-02760200183. Epub 2020 Sep 4. Mem Inst Oswaldo Cruz. 2020. PMID: 32901696 Free PMC article.
-
Blocking of the High-Affinity Interaction-Synapse Between SARS-CoV-2 Spike and Human ACE2 Proteins Likely Requires Multiple High-Affinity Antibodies: An Immune Perspective.Front Immunol. 2020 Sep 17;11:570018. doi: 10.3389/fimmu.2020.570018. eCollection 2020. Front Immunol. 2020. PMID: 33042151 Free PMC article. Review.
-
D614G and SARS-CoV-2 replication fitness.Signal Transduct Target Ther. 2021 Mar 1;6(1):99. doi: 10.1038/s41392-021-00498-3. Signal Transduct Target Ther. 2021. PMID: 33649290 Free PMC article. No abstract available.
-
BioAider: An efficient tool for viral genome analysis and its application in tracing SARS-CoV-2 transmission.Sustain Cities Soc. 2020 Dec;63:102466. doi: 10.1016/j.scs.2020.102466. Epub 2020 Aug 28. Sustain Cities Soc. 2020. PMID: 32904401 Free PMC article.
References
-
- Asmal M., Hellmann I., Liu W., Keele B.F., Perelson A.S., Bhattacharya T., Gnanakaran S., Daniels M., Haynes B.F., Korber B.T. A signature in HIV-1 envelope leader peptide associated with transition from acute to chronic infection impacts envelope processing and infectivity. PLoS ONE. 2011;6:e23673. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous